Shreya DasguptaScience’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.Last month, Anil Hebbar, a health entrepreneur, spoke to the media about his experience volunteering for a COVID-19 vaccine trial at King Edward Memorial Hospital in Mumbai, India.
He says he wanted to demystify the process of volunteering in a trial. But the hospital’s dean, Hemant Deshmukh, responded with a threat, telling The Times of India the hospital may “be forced to not give this volunteer the second shot” in the study.Hebbar ultimately did receive his second dose.